Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
about
Long-term follow-up after purine analogue therapy in hairy cell leukaemiaHairy cell leukemia: current conceptsCladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.[Hemato-oncological diseases].How I treat hairy cell leukemia.Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.Cladribine: not just another purine analogue?VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients.2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up.Structure characteristics of self-bonding boards during hot press for leukemia inhibitionCurrent status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.Historical aspects and milestones in the development of effective treatment for hairy cell leukemia.Combination therapies to improve the long-term outcome in hairy cell leukemia.Approach to the patient after relapse of hairy cell leukemia.Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.Chemo-immunotherapy for hairy cell leukemia.Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping.Infectious complications in hairy cell leukemia.Insight into the behavior of hairy cell leukemia by immunogenetic analysis.Hairy cell leukaemia: biological and clinical overview from immunogenetic insights.Hairy cell leukemia-new genes, new targets.Novel therapeutic options for relapsed hairy cell leukemia.How I manage patients with hairy cell leukaemia.Isolated Splenic Mycobacterial Disease: A Cause of Persistent Fever in a Hairy Cell Leukemia Patient.Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.Is it really possible to cure hairy cell leukemia patients only with frontline therapy?Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.Time to Cure Hairy Cell Leukemia.A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.Left behind: should minimal residual disease be treated in hairy cell leukemia?Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes.Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case
P2860
Q26776327-BCA67ABF-4D28-4E94-91A2-AA7D9EF79455Q28294251-8D0D7E37-4600-433E-920B-68F4B5E52E6BQ33392784-4412288D-3261-462D-B12E-FCAAA3D14CD8Q33410075-8E3482A5-8E4D-435C-B1F4-21F7E8BAC487Q33579506-CB792084-44B9-4334-BA17-862F3CAE24FDQ33844299-505E0A52-30CB-4A7F-A4C8-CD6CD0F87961Q34992373-0625D5FF-6580-4ECD-AA63-783E8564A475Q35002178-36D3D636-3A8A-445B-95EB-B0A5C6BE3355Q36208306-F10EBB3C-10FD-4475-BFED-8957409CC67BQ36654614-579521BC-858D-4236-BB9F-0D49F914E3A7Q36937512-BED974F1-8B2F-44BC-83C9-55ABFD6CD3D8Q37424784-E19146AA-F47A-4D12-94F8-F4B8E0CAE441Q37611065-DD97C229-6FAB-485F-9AEB-0B1CA5FB4BD2Q37611073-F3532F26-C32E-455B-9E5B-B1D983D02608Q37611080-FC66E81D-714D-4652-B7AE-97DF5F8B9324Q37816419-5B93DE67-7A64-43A9-A02B-D7F4F05B112BQ37854692-3C8D395E-0C71-4999-9A5B-A460FB627810Q37861184-B0AF4E2C-7F3B-4993-B9FD-241C638D0F1BQ37866770-4F507268-E62C-4860-9F49-E5055100E407Q37866773-1A52D716-42A2-44A9-98AD-0069407F604EQ37889776-F7C5E61A-F137-43EE-B4F1-FE9F7F4F012BQ38124726-86E6156F-57BB-4A05-B609-6221FEE944CAQ38308974-5E0783A1-7020-412F-B3D7-14FC15092529Q39113513-2F8FF1F0-0887-4222-AB74-D03BE848ECF0Q40344068-A42B9445-BC9E-45F6-9D61-5CD28F4BF9C8Q42291047-3C3D438E-1E83-48C9-8559-09ABC3FED718Q43531631-5FE49BCA-CCA6-4062-87C0-4CEBEA0BD6E2Q43708719-275B897B-5254-4B81-9DC6-09AF6E344BB3Q49742631-C4E48525-5FC9-49AD-B04D-EC9732E580CEQ50469577-B75974F5-BCC0-438A-A599-49482FA0CFC6Q53296252-7F68B9B8-C6DD-4C9D-893F-AED79B4A9FF1Q54311890-CF96CDFD-F3D3-453E-971D-E29C61BBE0BBQ58010843-8B8691A3-5D19-4BE2-8274-CE2929EAA5ED
P2860
Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@ast
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@en
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@nl
type
label
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@ast
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@en
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@nl
prefLabel
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@ast
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@en
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@nl
P2093
P50
P356
P1433
P1476
Long remissions in hairy cell ...... edian follow-up of 12.5 years.
@en
P2093
Anthony Woodman
Ilaria Del Giudice
John Swansbury
Nnenna Osuji
Rosa Ruchlemer
P304
P356
10.1002/CNCR.21447
P407
P577
2005-12-01T00:00:00Z